Key facts
- This page summarizes Rodney D. Windley's Form 4 filing for Aveanna Healthcare Holdings, Inc. (AVAH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Feb 2026, 21:13.
Rodney D. Windley - 17 Feb 2026 Form 4 Insider Report for Aveanna Healthcare Holdings, Inc. (AVAH)
- Reporting relationship
- Director
- Issuer ticker
- AVAH
- Reported as of
- 17 Feb 2026
- Net transaction value
- -$477,521
- SEC form
- 4
- Accepted by SEC
- 19 Feb 2026, 21:13:47 UTC
- Prior SEC filing
- 17 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jonathan Beckler, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Rodney D. Windley filed Form 4 for Aveanna Healthcare Holdings, Inc. (AVAH) on 19 Feb 2026.
Change
- Previous filing in this sequence was filed on 17 Feb 2026.
- Current net transaction value: -$477,521.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001354351
Primary reporting owner
Windley Rodney D
- Relationship
- Director
- Address
- C/O AVEANNA HEALTHCARE HOLDINGS INC., 400 INTERSTATE NORTH PARKWAY SE, ATLANTA
- Signature
- /s/ Jonathan Beckler, Attorney-in-Fact
- Signature date
- 19 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AVAH
transaction
Common Stock, par value $0.01 per share
Tax liability
- Transaction value
- $477,521
- Shares
- -60,217
- Change %
- -2.6%
- Price
- $7.93
- Shares after
- 2,258,017
- Date
- 17 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents performance-based restricted stock units withheld to pay taxes on the vesting of the Company's 2022 long-term incentive awards; not an open market transaction.